Our Connecticut-Based U.S. Innovation Hub

Ridgefield, Conn. is home to Boehringer Ingelheim’s U.S. headquarters and one of the company’s leading research and development sites. The 330-acre site, which runs completely on renewable, hydro-electric energy, is conveniently located just one-hour drive from New York City. The site has more than 1,900 employees, including 800 Innovation Unit colleagues with expertise across research, development, and translational medicine and clinical pharmacology. 

Consistently rated as a Global Top Employer and a top global pharmaceutical company, our mission is to discover and develop breakthrough therapies for patients. We prioritize investment in novel scientific concepts and first-in-class treatments in areas of high unmet patient needs.

Our dedicated scientists are doing just that. They’re tackling some of the most difficult challenges in healthcare and, together with our external research partners, they are working to accelerate the next breakthroughs that will transform patients’ lives – now and for generations to come.
 

Our Innovation Strategy: how we approach research and development
Our innovation strategy
Fostering Science | Boehringer Ingelheim US

Our Innovation Strategy: how we approach research and development

Disease never rests. So neither do we. Learn about how we are driving innovation in our research and development approach, with the patient at the core of everything with do.
Read more